tesa Labtec Overview
- Founded
-
1990

- Status
-
Acquired/Merged
- Employees
-
26

- Latest Deal Type
-
M&A
- Financing Rounds
-
2
tesa Labtec General Information
Description
Developer and distributor of oral films catering to pharmaceutical companies. The company engages in the design, development and distribution of topical, transdermal, buccal and other types of oral films and patches by using Transfilm technology.
Contact Information
Website
www.tesa-labtec.com
Formerly Known As
Labtec GmbH
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
AdhexPharma
Primary Office
- Raiffeisenstr. 4
- 40764 Langenfeld
- Germany
+49 02173 00000
tesa Labtec Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
tesa Labtec Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer and distributor of oral films catering to pharmaceutical companies. The company engages in the design, develop
Drug Discovery
Langenfeld, Germany
26
As of 2008
000000&0
tesa Labtec Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Lubrizol Life Science | Corporate Backed or Acquired | Bethlehem, PA | 00 | 000000&0 | ||
00000 0000 0000000 | Corporation | Burlington, Canada | 00 | 000.00 | 000000000 | 000.00 |
000 0000000 000000 | Private Equity-Backed | Andernach, Germany | 0000 | 000000000000 |
tesa Labtec Patents
tesa Labtec Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3912621-A1 | Propofol for diagnosis of primary headache | Inactive | 19-May-2020 | 000000000 | 0 |
EP-4153155-A1 | Propofol for diagnosis of primary headache | Pending | 19-May-2020 | 000000000 | |
EP-3912622-A1 | Oral film for safe administration of api | Inactive | 19-May-2020 | 000000000 | 0 |
EP-4153131-A1 | Oral film for safe administration of api | Pending | 19-May-2020 | 000000000 | |
EP-3384904-A1 | Pharmaceutical preparation for dermal administration | Inactive | 03-Apr-2017 | A61K9/7084 | 00 |
tesa Labtec Signals
tesa Labtec Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|